These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35000652)

  • 61. Predictors of remission from body dysmorphic disorder: a prospective study.
    Phillips KA; Pagano ME; Menard W; Fay C; Stout RL
    J Nerv Ment Dis; 2005 Aug; 193(8):564-7. PubMed ID: 16082302
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Comparing different machine learning techniques for predicting COVID-19 severity.
    Xiong Y; Ma Y; Ruan L; Li D; Lu C; Huang L;
    Infect Dis Poverty; 2022 Feb; 11(1):19. PubMed ID: 35177120
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evidence-based review: Screening body dysmorphic disorder in aesthetic clinical settings.
    Pereira IN; Chattopadhyay R; Fitzpatrick S; Nguyen S; Hassan H
    J Cosmet Dermatol; 2023 Jul; 22(7):1951-1966. PubMed ID: 36847707
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictors of Response to Cognitive-Behavioral Therapy for Body Dysmorphic Disorder.
    Greenberg JL; Phillips KA; Steketee G; Hoeppner SS; Wilhelm S
    Behav Ther; 2019 Jul; 50(4):839-849. PubMed ID: 31208692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Importance of immunometabolic markers for the classification of patients with major depressive disorder using machine learning.
    Sánchez-Carro Y; de la Torre-Luque A; Leal-Leturia I; Salvat-Pujol N; Massaneda C; de Arriba-Arnau A; Urretavizcaya M; Pérez-Solà V; Toll A; Martínez-Ruiz A; Ferreirós-Martínez R; Pérez S; Sastre J; Álvarez P; Soria V; López-García P
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar; 121():110674. PubMed ID: 36332700
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Review of Body Dysmorphic Disorder in Aesthetic Surgery Patients and the Legal Implications.
    Sweis IE; Spitz J; Barry DR; Cohen M
    Aesthetic Plast Surg; 2017 Aug; 41(4):949-954. PubMed ID: 28204935
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of the direct costs and cost effectiveness of serotonin reuptake inhibitors and associated adverse drug reactions.
    Sullivan PW; Valuck R; Saseen J; MacFall HM
    CNS Drugs; 2004; 18(13):911-32. PubMed ID: 15521793
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GWAS-based machine learning approach to predict duloxetine response in major depressive disorder.
    Maciukiewicz M; Marshe VS; Hauschild AC; Foster JA; Rotzinger S; Kennedy JL; Kennedy SH; Müller DJ; Geraci J
    J Psychiatr Res; 2018 Apr; 99():62-68. PubMed ID: 29407288
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Subthreshold body dysmorphic disorder in adolescents: Prevalence and impact.
    Schneider SC; Mond J; Turner CM; Hudson JL
    Psychiatry Res; 2017 May; 251():125-130. PubMed ID: 28199910
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevalence and predicting factors of perceived stress among Bangladeshi university students using machine learning algorithms.
    Rois R; Ray M; Rahman A; Roy SK
    J Health Popul Nutr; 2021 Nov; 40(1):50. PubMed ID: 34838133
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prediction of antiepileptic drug treatment outcomes of patients with newly diagnosed epilepsy by machine learning.
    Yao L; Cai M; Chen Y; Shen C; Shi L; Guo Y
    Epilepsy Behav; 2019 Jul; 96():92-97. PubMed ID: 31121513
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Multifactor Prediction of Embryo Transfer Outcomes Based on a Machine Learning Algorithm.
    Liu R; Bai S; Jiang X; Luo L; Tong X; Zheng S; Wang Y; Xu B
    Front Endocrinol (Lausanne); 2021; 12():745039. PubMed ID: 34795639
    [No Abstract]   [Full Text] [Related]  

  • 73. Derivation and validation of different machine-learning models in mortality prediction of trauma in motorcycle riders: a cross-sectional retrospective study in southern Taiwan.
    Kuo PJ; Wu SC; Chien PC; Rau CS; Chen YC; Hsieh HY; Hsieh CH
    BMJ Open; 2018 Jan; 8(1):e018252. PubMed ID: 29306885
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Machine learning-based prediction of outcomes of the endoscopic endonasal approach in Cushing disease: is the future coming?
    Zoli M; Staartjes VE; Guaraldi F; Friso F; Rustici A; Asioli S; Sollini G; Pasquini E; Regli L; Serra C; Mazzatenta D
    Neurosurg Focus; 2020 Jun; 48(6):E5. PubMed ID: 32480364
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation of a Machine Learning Model Based on Pretreatment Symptoms and Electroencephalographic Features to Predict Outcomes of Antidepressant Treatment in Adults With Depression: A Prespecified Secondary Analysis of a Randomized Clinical Trial.
    Rajpurkar P; Yang J; Dass N; Vale V; Keller AS; Irvin J; Taylor Z; Basu S; Ng A; Williams LM
    JAMA Netw Open; 2020 Jun; 3(6):e206653. PubMed ID: 32568399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A review of body dysmorphic disorder and its presentation in different clinical settings.
    Mufaddel A; Osman OT; Almugaddam F; Jafferany M
    Prim Care Companion CNS Disord; 2013; 15(4):. PubMed ID: 24392251
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Empirically Defining Treatment Response and Remission in Body Dysmorphic Disorder Using a Short Self-Report Instrument.
    Flygare O; Chen LL; Fernández de la Cruz L; Rück C; Andersson E; Enander J; Mataix-Cols D
    Behav Ther; 2021 Jul; 52(4):821-829. PubMed ID: 34134823
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Longitudinal course of pharmacotherapy in obsessive-compulsive disorder.
    Grant JE; Mancebo MC; Weinhandl E; Odlaug BL; Eisen JL; Rasmussen SA
    Int Clin Psychopharmacol; 2013 Jul; 28(4):200-5. PubMed ID: 23587985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.
    Frank E; Cassano GB; Rucci P; Thompson WK; Kraemer HC; Fagiolini A; Maggi L; Kupfer DJ; Shear MK; Houck PR; Calugi S; Grochocinski VJ; Scocco P; Buttenfield J; Forgione RN
    Psychol Med; 2011 Jan; 41(1):151-62. PubMed ID: 20380782
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Neuroimaging, genetic, clinical, and demographic predictors of treatment response in patients with social anxiety disorder.
    Frick A; Engman J; Alaie I; Björkstrand J; Gingnell M; Larsson EM; Eriksson E; Wahlstedt K; Fredrikson M; Furmark T
    J Affect Disord; 2020 Jan; 261():230-237. PubMed ID: 31655378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.